The math used to work. Fill scripts, manage inventory, keep the lights on, take home a reasonable margin. That model is breaking. According to the 2025 NCPA Digest, independent pharmacy in the United States represented a $103 billion marketplace in 2024 yet hit a 10-year low in gross profits, even as average prescription volume climbed to 67,601 per store. More volume, less money. That’s not a workflow problem you solve by hiring another tech.
The pharmacies finding their way out aren’t the ones squeezing harder on dispensing. They’re the ones redesigning their operation around clinical services, recurring touchpoints, and revenue streams that don’t sit at the mercy of PBM contracts. Here’s what that actually looks like on the ground.
Why the Dispense-Only Model Stopped Working
Independent pharmacies dispensed over 1.1 billion prescriptions in 2023, and roughly 96% of sales at the average independent come from prescriptions. That dependence is the problem. With government programs covering 52% of prescriptions in 2024 and below-cost reimbursements on high-cost drugs like GLP-1s, every additional script can actually shrink your margin instead of growing it.
The shift toward clinical care isn’t theoretical. The 2025 NCPA Digest shows that the majority of independents have already added non-dispensing services:
- 93% offer flu immunizations
- 92% offer non-flu immunizations
- 80% offer medication therapy management
- 73% perform blood pressure monitoring
- 55% provide services to long-term care patients
Offering those services and building an operation around them are different things. Most pharmacies bolt clinical care onto a workflow built for dispensing, then wonder why it doesn’t generate meaningful revenue. The hub model flips that. Dispensing becomes one revenue stream among several, and the operation is designed to make every patient visit count for more than picking up a bag.
The Operational Shifts That Actually Move the Needle
Becoming a healthcare hub isn’t about adding service line items to a menu. It’s about restructuring how patients move through your pharmacy, how your team spends its time, and how every interaction gets documented and (when possible) billed.
The first shift is physical: decouple clinical work from the dispensing counter. A patient walking in for a blood pressure check shouldn’t be stuck behind a line of script pickups. Healthcare hubs use a dedicated consultation room or screened-off area with its own scheduling. The counter handles transactional work; the consultation space handles clinical work. Without that physical separation, clinical services get crowded out every single day.
The second shift is human: route routine tasks away from the pharmacist. Pharmacist time is the most expensive and most constrained resource in the building. Hubs push data entry, inventory checks, refill outreach, payment processing, and initial intake for clinical services to trained technicians and automation, freeing the pharmacist for the work that only a pharmacist can do or bill for.
The third shift is informational: treat documentation as a revenue activity, not paperwork. Clinical services don’t get reimbursed if they aren’t documented to the standard payers require. Hubs build documentation into the workflow itself rather than treating it as something to catch up on at the end of the day.
All three shifts run into the same wall. Legacy pharmacy systems weren’t designed for any of this. A typical dispensing system tracks scripts, claims, and inventory; it doesn’t track clinical encounters, schedule appointments, or generate billable visit documentation. That’s the gap a lot of independents close with pharmacy management software development services that extend or replace what their existing system can do, connecting dispensing data, clinical encounters, scheduling, and billing into a single workflow. Whether that’s a custom build, an integration layer, or a configured platform, the principle is the same: the operation needs one record of what’s happening with each patient, not three or four disconnected ones.
When the systems support the workflow instead of fighting it, clinical services stop feeling like extra work and start feeling like part of the job.
The Services That Reliably Add Revenue
Not every clinical service is worth the time it takes to set up. Some have meaningful reimbursement and clear patient demand; others are mostly performative. The services with the strongest evidence base and the most stable reimbursement paths share three traits: recurring patient contact, a focus on chronic conditions or prevention, and a documented impact on downstream healthcare costs.
A 2023 research review found that pharmacist-provided care in community pharmacies reduced drug-related problems and improved patient education, clinical outcomes, and economic outcomes. Published modeling tied pharmacist-led adherence interventions in older Medicare patients to per-patient-per-year cost savings of roughly $108 for diabetes, $122 for hypertension, and $74 for cholesterol management. Payers notice those numbers, which is why reimbursement structures keep slowly expanding.
The services that tend to pay back the operational investment:
- Vaccinations beyond flu. Shingles, RSV, pneumococcal, Tdap, and travel vaccines are higher-margin and bring in patients who wouldn’t otherwise think of the pharmacy for preventive care.
- Comprehensive medication management for chronic disease. Diabetes, hypertension, and hyperlipidemia patients benefit most, and these are the patients who keep coming back.
- Point-of-care testing and test-to-treat. Strep, flu, COVID, and increasingly UTI testing with same-visit treatment under state protocols.
- Long-term care services. 55% of independents now serve LTC patients in some form, and the contracted nature of LTC work smooths out cash flow.
- Adherence packaging and medication synchronization. Less glamorous, but it pulls refills forward, reduces inventory waste, and locks in patient loyalty.
Which of these to pursue depends heavily on your state. As of early 2024, 19 states had some form of pharmacist provider status recognizing pharmacists for reimbursement under Medicaid, commercial insurance, or both, and more states have moved since. Some services pay well in California or Maryland and don’t pay at all two states over. Knowing what’s actually billable in your jurisdiction before you build out a service is the difference between adding revenue and adding overhead.
One detail owners often miss: the volume threshold for clinical services to pencil out is lower than it looks. A pharmacist running four billable encounters a day at typical MTM or test-and-treat reimbursement rates generates meaningful incremental revenue on hours already on payroll. The constraint is rarely demand. It’s the workflow space to deliver the service without dropping a ball at the counter, and the documentation discipline to capture the claim.
Getting Paid for What You’re Already Doing
Plenty of pharmacy owners are already providing clinical services and not billing for them, either because the documentation isn’t there or because nobody on staff knows the codes. That’s lost revenue you don’t have to add new services to capture.
A few practical moves close that gap. Document every clinical encounter in real time, including chief complaint, assessment, plan, and time spent. Without that, you can’t bill and you can’t defend against an audit. Verify both your state’s scope of practice (what you can do) and the reimbursement scope (what actually gets paid); they aren’t the same thing. Pursue credentialing with the payers you can. Medicare Advantage plans are increasingly contracting pharmacists as providers, and that doesn’t require federal provider status. It’s a contracting conversation, not a legislative one. And treat MTM as a recurring program, not a one-off. Eighty percent of independents say they offer it. Fewer have it set up as a structured, scheduled, repeatable encounter that gets billed and documented every time.
There’s also a quieter opportunity in pharmacy access itself. The USC-NCPA Pharmacy Access Initiative finds that roughly 1 in 8 U.S. neighborhoods lacks convenient access to pharmacy services, and that gap is widening as chain locations close. If you’re operating in or near a pharmacy shortage area, you’re the only healthcare touchpoint many of your patients have. Insurers and ACOs increasingly want partners in those areas, and that’s a conversation worth having directly with regional plans.
What This Looks Like at the Counter
The pharmacies pulling this off don’t look dramatically different from the outside. Signage is similar. Script volume is similar. What’s different is on the inside.
A typical day at a hub-model pharmacy includes scheduled consultations between dispensing peaks, technicians running first-pass intake on test-and-treat patients, and a pharmacist spending real time with three or four high-need patients rather than verifying their 200th script of the afternoon. The point-of-sale system isn’t the only system that matters; the scheduling, documentation, and billing systems are doing equal work. Patients come in for reasons other than picking up medication, and many of them come back monthly or quarterly because that’s how the relationship is structured.
The staffing model shifts too. The 2025 NCPA Digest pegs total employment across independent pharmacies at roughly 235,000 people, up from 205,000 the year before, and a meaningful share of that growth is in technician and clinical support roles, not new pharmacists. The pharmacies that have figured this out tend to operate with one or two more technicians than a comparable dispensing-only store, and those technicians spend a real portion of their week on clinical workflow: scheduling, intake, vitals, follow-up calls, and prep for billable encounters. That’s where the operational leverage comes from. The pharmacist isn’t doing more; the team around the pharmacist is doing more of what the pharmacist used to handle.
The economics aren’t magic. Clinical encounters don’t replace dispensing revenue dollar-for-dollar overnight. What they do is build a second revenue stream that doesn’t depend on PBM contracts, while making the dispensing side stickier. Patients in a structured MTM relationship don’t drift to mail-order. Over a few years, that’s the difference between a pharmacy that closes quietly and one that gets bought by the next generation.
The Takeaways
Three things actually matter if you’re trying to turn a dispensing-dependent business into a healthcare hub:
- The dispensing side is structurally squeezed. Volume isn’t going to save you.
- The clinical services with real reimbursement paths already exist. The bottleneck is operational design, not opportunity.
- The work doesn’t happen until the workflow, the systems, and the documentation all support it together. Adding services without those three is how good intentions die.
Pick the one service your state actually pays for, build the operation around delivering it properly, and bill it correctly every single time. That’s a quieter playbook than the industry conferences promise, but it’s the one that compounds.
